| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
QTRX (QTRX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. QTRX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.87M | $5.39M | - | |
| CEO | 813.8K | $2.34M | - | |
| CEO | 507.3K | $1.46M | - | |
| Dir | 313.3K | $902.2K | - | |
| Other | 154.1K | $443.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Hrusovsky E Kevin86 | Chairman And CEO | Sell | 868 | $29.79 | $25,860.24 | - | -46.9% | -63.0% | |
| Apr 1, 2022 | Roskey Mark T.89 | SVP, Strategic Partnerships | Sell | 171 | $29.79 | $5,094.59 | -0.8% | -46.9% | -63.0% | |
| Apr 1, 2022 | Fry John J83 | General Counsel &Secretary | Sell | 524 | $29.79 | $15,611.48 | -1.7% | -46.9% | -63.0% | |
| Apr 1, 2022 | Mattoon Dawn91 | Sr. VP, Diagnostics | Sell | 261 | $29.79 | $7,775.95 | -0.7% | -46.9% | -63.0% | |
| Mar 23, 2022 | Duffy David C.89 | SVP R&D And CTO | Sell | 3,266 | $30.00 | $97,980.00 | -5.6% | -42.2% | -62.7% | |
| Mar 1, 2022 | Roskey Mark T.89 | SVP, Strategic Partnerships | Sell | 166 | $31.46 | $5,221.81 | -0.4% | -46.6% | -66.6% | |
| Mar 1, 2022 | Hrusovsky E Kevin86 | Chairman And CEO | Sell | 589 | $31.46 | $18,529.74 | - | -46.6% | -66.6% | |
| Mar 1, 2022 | Fry John J83 | General Counsel &Secretary | Sell | 371 | $31.46 | $11,671.05 | -0.6% | -46.6% | -66.6% | |
| Mar 1, 2022 | Mattoon Dawn91 | Sr. VP, Diagnostics | Sell | 267 | $31.46 | $8,399.14 | -0.4% | -46.6% | -66.6% | |
| Feb 9, 2022 | Roskey Mark T.89 | SVP, Strategic Partnerships | Sell | 292 | $34.97 | $10,210.83 | -1.3% | -51.8% | -61.4% |